Dermata Therapeutics, Inc (DRMA) Misses Q3 EPS by 165c

Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q3 EPS of ($1.65).

For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.

You May Also Be Interested In

• Activist hedge fund Engine Capital has built a 1.5% stake in EPAM Systems - Reuters
• Zentek corrects day of week for OTC Markets trading start date
• Datacentrex invests $30M in LNG supplier Eagle LNG Partners